Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECT plus Agomelatine in Major Depressive Disorder
NCT04181567Phase 4Completed
- Sponsor
- Kaohsiung Municipal Kai-Suan Psychiatric Hospital
- Start
- Mar 2014
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of agomelatine in major depressive disorder (MDD), sponsored by Kaohsiung Municipal Kai-Suan Psychiatric Hospital. Started Mar 2014; status: completed.
02
Drugs
agomelatine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04181567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04181567.